✦ LIBER ✦

ZD1839 effective against NSCLC in phase II trials

✍ Scribed by Claudia Orellana

Book ID: 117782629
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 104 KB
Volume: 3
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(02)00803-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ZD1839 (IRESSA™) in pa

Phase II trial of ZD1839 (IRESSA™) in patients with advanced renal cell carcinoma

✍ Beverly Drucker; Jennifer Bacik; Michelle Ginsberg; Stephanie Marion; Paul Russo 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 58 KB

ZD0473 phase II monotherapy trial in sec

ZD0473 phase II monotherapy trial in second-line ovarian cancer

✍ M. Gore; R.J. Atkinson; L. Dirix; D. Rischin; P. Beale; P. Harnet; D. Hacking; H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

SBRT in inoperable stage I NSCLC: Phase

SBRT in inoperable stage I NSCLC: Phase II trial

✍ Navarro Martin, A.; Piñeiro Retif, R.; Arnaiz, M.; Rosales, S.; Sancho, I.; Garc 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 54 KB

A phase II trial of PFL in advanced NSCL

A phase II trial of PFL in advanced NSCLC

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A phase II-trial wiht sulofenur in advan

A phase II-trial wiht sulofenur in advanced NSCLC

✍ Gatzemeier, U.; Neuhauss, R.; Drings, P.; Manegold, C. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 113 KB

1124 ORAL Results of a randomized, doubl

1124 ORAL Results of a randomized, double-blind phase II trial of ZD6474 versus gefitinib in patients with NSCLC

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 290 KB